Digitalising clinical trials can improve accessibility and engagement for participants, as well as data collection and analytics. It has the potential to lower clinical trial expenses, reduce manual labour and trial time, and enhance supply chains, distribution, marketing, and sales to transform the clinical trials industry.
Recommended Buyer's Guides
Digital technology in clinical trials can expedite the pace of generating health data and evidence and improve trial efficiency while providing a more patient-friendly trial experience. Clinical bioinformatics has emerged as a powerful tool to understand the molecular mechanisms involved in the development of new therapies.
Best-rated IT and bioinformatics services
Different software packages are used to evaluate and interpret biological data, while instrumentation and other supplies are required for various analyses and research.
Clinical Trials Arena has listed some of the leading IT and bioinformatics suppliers for clinical trials and the drug industry, based on its intel, insights and decades of experience in the sector. The companies on the list offer services and products such as scientific animations and interactive graphics for drug development, IT equipment analysis, artificial intelligence (AI) platforms for tracking clinical trials, and bioinformatics software development.
The information given in the download document is intended for clinical trial executives, clinical trial coordinators, clinical research coordinators, trial managers, clinical data managers, clinical research scientists, research associates, suppliers, programmers, and other individuals involved in operations in the clinical trials industry.
See Also:
Demand for clinical trial technology
The use of technology in clinical trials has eased several major challenges related to the recruitment and retention of patients, access to non-traditional data sets, data capturing, remote patient monitoring, and overall patient experience by reducing patient burdens such as travel.
Wearable devices, virtual clinical trials, and virtual clinical visits are some novel clinical trial technology trends that are growing in popularity. They support the development of more decentralised and hybrid clinical trial designs.
Pharmaceutical companies are increasing looking to implement clinical trial technologies to reduce trial failures and address the challenges of incomplete patient recruitment, long and delayed trial processes, and post-market approval. Technologies such as AI, big data and blockchain will support increasing investment in clinical trial technology to improve clinical trial payments and clinical trial management systems (CTMS).
Growing role of bioinformatics companies in transforming clinical research
Bioinformatics helps in acquiring and interpreting quantitative information in medical research, as well as allowing new methods in clinical trial design and analysis to be researched and understood.
New technologies such as molecular docking, molecular dynamics simulation, and proteomics have expedited and eased the drug discovery process. Bioinformatics can help in generating knowledge related to diseases, clinical trials data management, and the use of clinical data for secondary research.
